Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "FactSet ."


13 mentions found


While together, the Nasdaq's nearly 20% annual gain in 1983 was quite respectable, the second half was clearly less fruitful. "I don't like the setup now for the beginning of the second half, although I think the second half could be strong." .SPX YTD mountain S & P 500 YTD peformance For the broader S & P 500, recent history suggests that its first-half strength, rising almost 16%, could be built on over the next six months. "That's why I think a strong first half tends to carry over into a strong second half." Stovall said he can envision some choppiness ahead for the S & P 500.
Persons: Jim Cramer, Jim, Wells, JPMorgan Chase, Morgan Stanley, Stocks, tech's, Sam Stovall Sam Stovall, Stovall, UBS Global Wealth Management Claudia Panseri, Claudia Panseri, Panseri, Jim Cramer's, Spencer Platt Organizations: Nasdaq, Procter & Gamble, Club, JPMorgan, Big Tech, FactSet, Federal Reserve, CFRA Research, CNBC, UBS Global Wealth Management, New York Stock Exchange, Getty Locations: U.S
Publicis Groupe SA expects to hit organic growth this year in the top half of its previously stated range of 3% to 5%. Photo: BENOIT TESSIER/REUTERSPublicis Groupe SA reported higher-than-expected organic growth of 7.1% in the first quarter, and the advertising holding company said demand for its services continues despite the choppy macroeconomic environment. Analysts expected 5.89% growth in the quarter, according to FactSet .
Despite peaks and valleys, stocks closed the first quarter on an up note, with the S & P 500 rallying more than 7% and the tech-fueled Nasdaq soaring about 16%. .SPX .DJI YTD line S & P 500 gains so far in 2023 Indeed, the market has lived through a lifetime of scary headlines in the first three months of 2023. Despite repeated protestations from Fed officials that they are taking the higher-for-longer approach on interest rates, markets still expect cuts. AAPL .SPX YTD mountain Apple compared to the S & P 500 Only five of the 11 S & P 500 sectors are positive for the year, despite the substantial rally for the index. The net profit margin for the S & P 500 also is expected to edge lower to 11.2%.
Olive Garden Parent Is Packing Them In
  + stars: | 2023-03-23 | by ( Spencer Jakab | ) www.wsj.com   time to read: 1 min
Casual-dining chain Olive Garden is performing better than the upscale Capital Grille. The best restaurant stock on the block doesn’t need to have the best restaurant on the block. Olive Garden parent Darden Restaurants demonstrated that again on Thursday morning when it released pleasing financial results and encouraging guidance. It continues to pull ahead of the casual-dining chain pack by getting more customers in the door than peers in a tough economic environment. Darden reported that same restaurant sales during its fiscal third quarter rose by 11.7%, handily beating analyst consensus based on data from FactSet .
Walmart said December was the largest sales volume month in its history. Walmart Inc. reported strong quarterly sales Tuesday as cash-strapped shoppers gravitated to the discount retailer for food and other essentials and continued to pay higher prices on many items compared with last year. U.S. comparable sales, those from stores and digital channels operating for at least 12 months, rose 8.3% in the quarter ended Jan. 27, compared with the same period last year. That beat analyst expectations of 4.9% growth, according to estimates from FactSet .
However, defensive stocks are likely to better withstand a market downturn given their strong balance sheet and consistent revenue stream. With that in mind, CNBC Pro looked for Wall Street's favorite defense stocks. At least 60% of the analysts covering the stock rate it a buy, per FactSet. Visa and Mastercard have more than 70% of the analysts covering the stocks rating them a buy. The stock has 17% upside to the average analyst price target and 68% of analysts covering it rate the name a buy.
Because Humira sales won’t decline all at once, AbbVie will have time to switch many of its patients to its newer immunology drugs. AbbVie is finally losing its U.S. monopoly on blockbuster drug Humira as multiple lower-priced rivals are set to enter the market. That is thanks to steep discounts AbbVie is offering middlemen this year that will hurt profitability but help the biotech largely fend off competition for now. AbbVie said Thursday that it expects 2023 adjusted earnings of between $10.70 and $11.10 a share, a steep decline from last year and well below the average among analysts surveyed by FactSet . The company predicted Humira sales will decline about 37% to $13.7 billion.
Microsoft Corp. likely recorded its slowest sales growth in more than six years last quarter as economic concerns cooled demand for its software and cloud services. The Redmond, Wash., firm’s revenue growth is expected to slow to less than 3% in the three months through Dec. 31 compared with a year earlier while its net income is expected to fall more than 8%, according to financial analysts surveyed by FactSet . They predicted the company would announce sales of $53.12 billion and a net income of $17.21 billion for the period.
Tesla says changes in how the company produces cars and distributes them to customers left more vehicles in transit to their final destination at year-end. Tesla Inc. delivered fewer vehicles in 2022 than it initially targeted, capping a year during which the stock suffer its worst annual performance as demand appeared to soften and Covid-related production disruptions persisted. Elon Musk‘s electric-vehicle maker said Monday that it delivered around 1.31 million vehicles last year, up roughly 40% from 2021. The company would have needed to hand over more than 1.4 million vehicles to meet its initial goal of increasing deliveries by 50% or more. Tesla signaled in October that it likely would come up short of its target, and Wall Street had already moderated its delivery expectations to around 1.34 million for 2022, according to FactSet .
It's good to see stocks rally going into December, but the continuing decline in earnings estimates is worrisome. Since the start of the quarter, fourth-quarter earnings estimates for the S & P 500 have gone down 5.6% to $54.58 from $57.79, according to FactSet . 2023 earnings estimates are also coming down at a fairly rapid pace. The problem is that estimates have been coming down at the same time stock prices have been going up . FactSet noted that on average analysts have overestimated yearly earnings by about 7% over the past 25 years.
UnitedHealth Group is known for providing conservative financial outlooks and then beating those projections. From a financial standpoint, the pandemic years have been good for managed care companies. Hospitals faced unprecedented labor shortages in recent years as nurses and doctors quit their jobs, forcing many patients to defer costly care, a boon to insurers. One data point says it all: the medical loss ratio at UnitedHealth Group , the largest managed care company, has beaten the Wall Street analyst consensus in 10 of the last 11 fiscal quarters, according to data from FactSet .
Merck Lifts Outlook After Quarterly Sales Rise 14%
  + stars: | 2022-10-27 | by ( Sabela Ojea | ) www.wsj.com   time to read: 1 min
Merck says sales climbed to $15 billion in the latest quarter, ahead of market expectations. Merck & Co. raised its revenue outlook after posting a 14% rise in third-quarter sales on growing demand for its oncology treatments and vaccines. The pharmaceutical giant on Thursday said sales climbed to $15 billion in the quarter ended Sept. 30, ahead of market expectations of nearly $14.1 billion, according to FactSet .
The dollar's record rally is wreaking havoc on some of the biggest companies in the world this earnings season. Morgan Stanley's Michelle Weaver said in a note to clients this week that the dollar's rally presents a headwind to earnings for U.S. companies, which make roughly 30% of sales abroad combined. Technology stocks are among the biggest behemoths so far to report headwinds from the dollar's strength this earnings season. Meanwhile, consumer discretionary names like Hasbro and Mattel are also feeling the pinch from the dollar's rally. While companies remain cautious going forward, some analysts and big investors also believe the dollar's rally has already shown signs that it's rolling over.
Total: 13